Sanofi and partner seek European Medicines Agency review for sleep sickness product

PARIS (Reuters) - French healthcare group Sanofi, along with its business partner, has asked the European Medicines Agency (EMA) to review the fexinidazole product for the treatment of sleeping sickness, the company said on Wednesday.


from Reuters: Health News http://ift.tt/2nrs2Gg

Comments

Popular posts from this blog

ICE arrest of Kansas professor highlights complicated paths to citizenship - NBCNews.com

White House reels as FBI director contradicts official claims about alleged abuser - Washington Post

Trump calls meeting on biofuels policy blamed by bankrupt refiner